Growth Metrics

Mesoblast (MESO) Net Margin (2016 - 2023)

Mesoblast recorded quarterly Net Margin of 771.54% in Q2 2023, up 124.95% quarter-over-quarter from 3092.83% in Q1 2023, and up 391417.0% year-over-year from N/an in Q2 2022.

Mesoblast's Net Margin history runs 8 years deep, the most recent figure standing at 771.54% for Q2 2023.

  • In Q2 2023, Net Margin rose 391417.0% year-over-year to 771.54%; the TTM figure through Mar 2023 stood at 1611.65% (down 112776.0% YoY), while the FY2025 annual figure was 593.92%, changed N/A from the prior year.
  • Net Margin came in at 771.54% for Q2 2023 at Mesoblast, up from 3092.83% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 2396.35% in Q1 2019 to a low of 3919.87% in Q1 2021.
  • A 5-year average of 843.21% and a median of 999.36% in 2021 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin sank 465331 bps in 2021 and jumped 391417 bps in 2023, its largest moves.
  • Mesoblast's Net Margin stood at 1248.55% in 2019, then slumped by 280 bps to 2241.68% in 2020, then jumped by 149 bps to 1089.21% in 2021, then advanced by 14 bps to 1236.67% in 2022, then slumped by 38 bps to 771.54% in 2023.
  • According to Business Quant data, Net Margin over the past three periods registered 771.54%, 3092.83%, and 1236.67% for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 Mesoblast 23.40 Bn 23.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 771.54%
Mar 31, 2023 -3,092.83%
Dec 31, 2022 1,236.67%
Sep 30, 2022 -1,170.06%
Jun 30, 2022 -3,142.63%
Mar 31, 2022 -1,063.75%
Dec 31, 2021 1,089.21%
Sep 30, 2021 -934.97%
Jun 30, 2021 -1,229.66%
Mar 31, 2021 -3,919.87%
Dec 31, 2020 -2,241.68%
Sep 30, 2020 -1,880.77%
Jun 30, 2020 -172.79%
Mar 31, 2020 733.45%
Dec 31, 2019 1,248.55%
Sep 30, 2019 -292.95%
Jun 30, 2019 -3,511.59%
Mar 31, 2019 2,396.35%
Dec 31, 2018 2,021.69%
Sep 30, 2018 -1,938.17%
Jun 30, 2018 -1,225.53%
Mar 31, 2018 2,132.90%
Dec 31, 2017 232.25%
Sep 30, 2017 -598.13%
Jun 30, 2017 -4,802.47%
Mar 31, 2017 -1,085.90%
Dec 31, 2016 -4,630.72%
Sep 30, 2016 -9,081.65%
Jun 30, 2016 -434.23%
Mar 31, 2016 -548.65%